These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 12151398
1. Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. O'Neil PK, Sun G, Yu H, Ron Y, Dougherty JP, Preston BD. J Biol Chem; 2002 Oct 11; 277(41):38053-61. PubMed ID: 12151398 [Abstract] [Full Text] [Related]
5. Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication. Kharytonchyk S, King SR, Ndongmo CB, Stilger KL, An W, Telesnitsky A. J Mol Biol; 2016 Jun 05; 428(11):2275-2288. PubMed ID: 27075671 [Abstract] [Full Text] [Related]
8. Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. Kim T, Mudry RA, Rexrode CA, Pathak VK. J Virol; 1996 Nov 05; 70(11):7594-602. PubMed ID: 8892879 [Abstract] [Full Text] [Related]
9. The effect of increased processivity on overall fidelity of human immunodeficiency virus type 1 reverse transcriptase. Rezende LF, Kew Y, Prasad VR. J Biomed Sci; 2001 Nov 05; 8(2):197-205. PubMed ID: 11287751 [Abstract] [Full Text] [Related]
10. Fidelity of HIV-1 reverse transcriptase copying a hypervariable region of the HIV-1 env gene. Ji J, Loeb LA. Virology; 1994 Mar 05; 199(2):323-30. PubMed ID: 7510083 [Abstract] [Full Text] [Related]
11. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy. Junker U, Böhnlein E, Veres G. Gene Ther; 1995 Nov 05; 2(9):639-46. PubMed ID: 8548553 [Abstract] [Full Text] [Related]
12. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis. Weiss KK, Chen R, Skasko M, Reynolds HM, Lee K, Bambara RA, Mansky LM, Kim B. Biochemistry; 2004 Apr 20; 43(15):4490-500. PubMed ID: 15078095 [Abstract] [Full Text] [Related]
14. Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus. Klaver B, Berkhout B. J Virol; 1994 Jun 20; 68(6):3830-40. PubMed ID: 8189520 [Abstract] [Full Text] [Related]
16. A Novel Leu92 Mutant of HIV-1 Reverse Transcriptase with a Selective Deficiency in Strand Transfer Causes a Loss of Viral Replication. Herzig E, Voronin N, Kucherenko N, Hizi A. J Virol; 2015 Aug 20; 89(16):8119-29. PubMed ID: 25995261 [Abstract] [Full Text] [Related]
17. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. Mansky LM, Temin HM. J Virol; 1995 Aug 20; 69(8):5087-94. PubMed ID: 7541846 [Abstract] [Full Text] [Related]
18. Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases. Menéndez-Arias L. Prog Nucleic Acid Res Mol Biol; 2002 Aug 20; 71():91-147. PubMed ID: 12102562 [Abstract] [Full Text] [Related]